Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-3-28
|
pubmed:abstractText |
A 74-year-old man has been known to have scleroderma for 5 years. Two months before the hospitalization, his blood pressure was rapidly elevated, and progressive renal impairment and ulcerations of the fingers manifested. Then he was diagnosed to have a crisis of scleroderma. The treatment with a new long-acting angiotensin I converting enzyme inhibitor, enalapril maleate (MK-421), normalized the blood pressure and protected the progress of renal impairment without side effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0040-8727
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
433-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6098974-Aged,
pubmed-meshheading:6098974-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:6098974-Antihypertensive Agents,
pubmed-meshheading:6098974-Dipeptides,
pubmed-meshheading:6098974-Enalapril,
pubmed-meshheading:6098974-Humans,
pubmed-meshheading:6098974-Kidney Diseases,
pubmed-meshheading:6098974-Male,
pubmed-meshheading:6098974-Scleroderma, Systemic
|
pubmed:year |
1984
|
pubmed:articleTitle |
Successful treatment of the crisis of scleroderma with enalapril maleate (MK-421).
|
pubmed:publicationType |
Journal Article,
Case Reports
|